Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Disposition to Issuer of 54 SNGX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | SOLIGENIX, INC. (SNGX) | Disposition to Issuer | 54 | n/a |
| Sep 18, 2026 | SOLIGENIX, INC. (SNGX) | Grant/Award | 78,947 | n/a |
| Jan 6, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Grant/Award | 4,000 | n/a |
| Jun 28, 2025 | NEXGEL, INC. (NXGL) | Grant/Award | 30,000 | n/a |
| Jun 20, 2025 | SOLIGENIX, INC. (SNGX) | Grant/Award | 17,647 | n/a |
| Jan 7, 2025 | PTC THERAPEUTICS, INC. (PTCT) | Grant/Award | 4,000 | n/a |
| Dec 13, 2024 | SOLIGENIX, INC. (SNGX) | Grant/Award | 8,646 | n/a |
| Dec 4, 2024 | PTC THERAPEUTICS, INC. (PTCT) | Exercise/Conversion | 12,000 | $612.0K |
| Nov 22, 2024 | NEXGEL, INC. (NXGL) | Purchase | 3,636 | $10.0K |
| Sep 17, 2024 | NEXGEL, INC. (NXGL) | Grant/Award | 25,000 | n/a |